INSULET CORP 8-K

What Happened
Insulet Corporation (PODD) filed an 8-K (Item 1.01) reporting that it and NXP USA, Inc. entered into an Addendum to their Purchase Agreement. The 2026 Addendum is effective January 1, 2026 and was entered into on January 29, 2026; it extends the term of the original agreement (dated October 12, 2017) and amends certain terms related to pricing, product volume, product order flexibility and other matters. The Addendum is filed as Exhibit 10.1 to the report.

Key Details

• Parties: Insulet Corporation and NXP USA, Inc.
• Effective date of Addendum: January 1, 2026; entered into on January 29, 2026.
• Changes: extension of the original Purchase Agreement term and amendments to pricing, product volume, and order flexibility.
• Disclosure: full Addendum attached as Exhibit 10.1; certain portions of the exhibit are treated as confidential and omitted per SEC rules.

Why It Matters
This filing documents a material update to Insulet’s supply relationship with NXP, a supplier for components used in Insulet’s products. Extending the agreement and updating pricing/volume/order terms can affect Insulet’s supply stability, manufacturing planning and potential cost structure. The 8-K does not disclose dollar amounts or specific pricing changes, so investors should note the contract revision but look for future disclosures (e.g., in quarterly reports or press releases) for any quantified financial impact.